Results (per patient) assuming equal sensitivity of ENB and TTNA
| Economic outcome | ENB | TTNA | Incremental |
| Diagnostic strategy cost | £1863 | £1630 | £232 |
| Cancer treatment cost | £17 677 | £17 677 | £0 |
| Cost of delayed diagnosis | £10 | £10 | £0 |
| Cost of adverse events | £149 | £469 | −£320 |
| Total cost per patient | £19 698 | £19 786 | −£88 |
| QALYs | 6.45048 | 6.45048 | 0.00000 |
| Disutility | −0.00086 | −0.00349 | 0.00263 |
| Total QALY per patient | 6.44962 | 6.44699 | 0.00263 |
| ICER | Dominated | ||
| Incremental NMB | £140 | ||
ENB, electromagnetic navigation bronchoscopy; ICER, Incremental cost-effectiveness ratio; NMB, net monetary benefit; QALYs, quality-adjusted life-years; TTNA, transthoracic needle aspiration.